Results 91 to 100 of about 55,991 (251)
Journal of Cardiovascular Electrophysiology, EarlyView.ABSTRACT Background In patients with structural heart disease (SHD) and moderately impaired left ventricular ejection fraction (LVEF > 35%), data on outcomes after ventricular tachycardia (VT) ablation remain limited. This analysis focuses on VT recurrence after ablation in patients presenting with sustained VT and LVEF > 35% within a secondary ...
Said‐Elias Waezsasa +14 more
wiley +1 more source
Journal of Molecular and Cellular Cardiology PlusIntroduction: Hypertrophic cardiomyopathy (HCM) results from pathogenic variants in sarcomeric protein genes that increase myocyte energy demand and lead to cardiac hypertrophy.
Arpana Vaniya +11 more
doaj +1 more source
Journal of Fish Diseases, Volume 48, Issue 4, April 2025.ABSTRACT Atlantic cod farming experiences renewed growth in Norway, and increased awareness is essential to address emerging diseases in this species. There are few reports on gill diseases in cod, and to date, no viral gill infections of cod have been documented. In this study, we collected samples from three sequential time points in summer 2023 from
Mona C. Gjessing +4 more
wiley +1 more source
Genomic Medicine Sweden: Advancing precision medicine at the national level
Journal of Internal Medicine, EarlyView.Abstract High‐throughput sequencing has transformed clinical diagnostics of rare diseases (RD), cancer and infectious diseases by enabling the identification of disease‐causing genetic alterations and facilitating individualised treatment and care.
Anders Edsjö +58 more
wiley +1 more source
Pacing and Clinical Electrophysiology, EarlyView.ABSTRACT Background Permanent pacemaker (PPM) implantation is recommended in patients with sinus node dysfunction (SND). In patients with coexisting heart failure with preserved ejection fraction (HFpEF), clinicians may be hesitant to treat SND due to concerns about exacerbating heart failure.
Nicole Habel +4 more
wiley +1 more source
Pacing and Clinical Electrophysiology, EarlyView.Abstract Background Implantable cardioverter‐defibrillator (ICD) therapy relies on reliable right ventricular leads for pacing, sensing, and defibrillation. The INVICTA DF4 lead is an active‐fixation, quadripolar design intended to optimize implant workflow and long‐term safety and performance. Methods APOLLO was a prospective, multicenter, single‐arm,
Klaus K. Witte +13 more
wiley +1 more source
Natural products targeting regulated cell deaths for adriamycin-induced cardiotoxicity
Cell Death DiscoveryAdriamycin (ADR), as an anti-cancer drug in routine clinical application, is utilized to treat various cancers such as ovarian cancer, hematological malignant tumor, and endometrial carcinoma.
Zheng Wang +7 more
doaj +1 more source
First Experience With Extravascular Implantable Cardioverter‐Defibrillator Under Deep Sedation
Pacing and Clinical Electrophysiology, EarlyView.ABSTRACT Background The Extravascular Implantable Cardioverter‐Defibrillator (EV‐ICD) utilizes a substernal lead to provide defibrillation and anti‐tachycardia pacing (ATP) while avoiding transvenous complications. General anesthesia (GA) was applied for implantation procedures in the EV‐ICD pivotal trial and is currently recommended by the ...
Nibras Soubh +9 more
wiley +1 more source
Pacing and Clinical Electrophysiology, EarlyView.ABSTRACT Background Despite advancements in catheter ablation (CA) technique and expertise, success rates of atrial fibrillation (AF) ablation have not substantially improved in recent years. Treating patients with advanced age and higher comorbidities may limit success rates while increasing complications.
Eran Leshem +5 more
wiley +1 more source
Multimodality Imaging in Hypertrophic Cardiomyopathy. [PDF]
Card Fail RevEscribano D, Díaz-Peláez E, Delgado V.
europepmc +2 more sources